Juno, CAR-T Peers Rise After Report Of Potential Celgene Deal
January 17, 2018 at 12:59 PM EST
Shares of Juno Therapeutics are on the rise after the Wall Street Journal reported that the company is in talks to be acquired by Celgene.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|